# TPH1 inhibits bladder tumorigenesis by targeting HIF-1α pathway in bladder cancer

## TL;DR

This study shows that TPH1 inhibits bladder cancer growth by suppressing the HIF-1α pathway, suggesting TPH1 could be a new treatment target.

## Contribution

The novel finding is that TPH1 inhibits bladder cancer progression by targeting the HIF-1α pathway, offering a potential therapeutic strategy.

## Key findings

- TPH1 overexpression reduces cell survival and proliferation in bladder cancer cells.
- TPH1 deficiency increases colony formation and HIF-1α activity.
- TPH1 suppresses HIF-1α, which is linked to reduced cancer cell proliferation.

## Abstract

BCa is the most common cancer of the urinary system. TPH1 has been reported to be associated with distinct tumorigenesis. However, the role of TPH1 in BCa remains to be clarified.

Our aim is to demonstrate the molecular mechanism of TPH1 in BCa carcinogenesis and development.

In research, we explored the effect of TPH1 on T24 cells. Colony formation, soft agar, and cell proliferation assays were used to determine the survival and proliferative capacity of cells. Moreover, TPH1−/− cell lines were analyzed using CRISP-CAS9, and the recovery experiment was conducted. Realtime fluorescence quantitative PCR (qPCR) and Western blot were used to detect HIF-1α mRNA levels and TPH1 protein.

The TPH1 expression is lower in tumor tissues than in normal tissues. Colony formation, soft agar, and cell proliferation assays revealed that the overexpression of TPH1 declined cells survival. Moreover, the deficiency of TPH1 increased the number of clones. These results suggested that survival rate of TPH1 overexpression was repressed in cells. In addition, we found that HIF-1α activity was significantly downregulated with an increase in TPH1. The transcriptional activity of survivin was increased with TPH1−/− cells. Then, the proliferative ability of TPH1−/− cells was almost similar to the wild type levels with the treatment of LW6, TPH1 might play a major role to repress HIF-1α activity.

Taken together, these results suggested that increasing TPH1 activity could inhibit survival and proliferation of cells via HIF-1α pathway. TPH1 may be a potential target for human BCa therapy.